Work2Prevent, an Employment Intervention Program as HIV Prevention for Young Men Who Have Sex With Men and Transgender Youth of Color (Phase 3): Protocol for a Single-Arm Community-Based Trial to Assess Feasibility and Acceptability in a Real-World Setting.

HIV/AIDS LGBTQ YMSM YTW gender nonconforming youth homelessness sex work unemployment young men who have sex with men young transgender women youth

Journal

JMIR research protocols
ISSN: 1929-0748
Titre abrégé: JMIR Res Protoc
Pays: Canada
ID NLM: 101599504

Informations de publication

Date de publication:
11 Sep 2020
Historique:
received: 02 03 2020
accepted: 25 06 2020
revised: 25 06 2020
entrez: 11 9 2020
pubmed: 12 9 2020
medline: 12 9 2020
Statut: epublish

Résumé

In the United States, young cisgender men who have sex with men (YMSM), young transgender women (YTW), and gender nonconforming (GNC) youth face elevated rates of HIV infection. However, racial and ethnic disparities in adolescent HIV infection cannot be attributed to individual-level factors alone and are situated within larger social and structural contexts that marginalize and predispose sexual and gender minority youth of color to HIV. Addressing broader ecological factors that drive transmission requires interventions that focus on the distal drivers of HIV infection, including violence exposure, housing, food insecurity, educational attainment, and employment. Given the ways that economic instability may make YMSM, YTW, and GNC youth of color vulnerable to HIV exposure, this study focuses on employment as an HIV prevention intervention. More specifically, the intervention, called Work2Prevent (W2P), targets economic stability through job readiness and employment as a means of preventing behaviors and factors associated with adolescent and young adult HIV, such as transactional sex work and homelessness. The intervention was adapted from iFOUR, an evidence-based employment program for HIV-positive adults in phase 1 of this study, and pilot tested in a university-based setting in phase 2. This paper aims to describe the protocol for the community-based test phase of W2P. The purpose of this phase was to pilot test a tailored, theoretically informed employment intervention program among YMSM, YTW, and GNC youth of color within a lesbian, gay, bisexual, transgender, and queer (LGBTQ) community setting. The employment intervention was pilot tested using a single-arm pretest-posttest trial design implemented among a sample of vulnerable YMSM, YTW, and GNC youth of color using services within a community-based LGBTQ center. Assessments will examine intervention feasibility, acceptability, and preliminary estimates of efficacy. Phase 3 of W2P research activities began in May 2019 and was completed in December 2019. Overall, 41 participants were enrolled in the community-based pilot. This study will assess intervention feasibility and acceptability in the target populations and determine preliminary efficacy of the intervention to increase employment and reduce vulnerability to HIV when implemented in a community-based setting serving LGBTQ youth of color. Testing the intervention in a community setting is an opportunity to evaluate how recruitment, retention, and other outcomes are impacted by delivery in a venue akin to where this intervention could eventually be used by nonresearchers. If W2P demonstrates feasibility and acceptability, a larger multisite trial implemented in multiple community settings serving YMSM, YTW, and GNC youth of color is planned. ClinicalTrials.gov NCT03313310; https://clinicaltrials.gov/ct2/show/NCT03313310. DERR1-10.2196/18051.

Sections du résumé

BACKGROUND BACKGROUND
In the United States, young cisgender men who have sex with men (YMSM), young transgender women (YTW), and gender nonconforming (GNC) youth face elevated rates of HIV infection. However, racial and ethnic disparities in adolescent HIV infection cannot be attributed to individual-level factors alone and are situated within larger social and structural contexts that marginalize and predispose sexual and gender minority youth of color to HIV. Addressing broader ecological factors that drive transmission requires interventions that focus on the distal drivers of HIV infection, including violence exposure, housing, food insecurity, educational attainment, and employment. Given the ways that economic instability may make YMSM, YTW, and GNC youth of color vulnerable to HIV exposure, this study focuses on employment as an HIV prevention intervention. More specifically, the intervention, called Work2Prevent (W2P), targets economic stability through job readiness and employment as a means of preventing behaviors and factors associated with adolescent and young adult HIV, such as transactional sex work and homelessness. The intervention was adapted from iFOUR, an evidence-based employment program for HIV-positive adults in phase 1 of this study, and pilot tested in a university-based setting in phase 2.
OBJECTIVE OBJECTIVE
This paper aims to describe the protocol for the community-based test phase of W2P. The purpose of this phase was to pilot test a tailored, theoretically informed employment intervention program among YMSM, YTW, and GNC youth of color within a lesbian, gay, bisexual, transgender, and queer (LGBTQ) community setting.
METHODS METHODS
The employment intervention was pilot tested using a single-arm pretest-posttest trial design implemented among a sample of vulnerable YMSM, YTW, and GNC youth of color using services within a community-based LGBTQ center. Assessments will examine intervention feasibility, acceptability, and preliminary estimates of efficacy.
RESULTS RESULTS
Phase 3 of W2P research activities began in May 2019 and was completed in December 2019. Overall, 41 participants were enrolled in the community-based pilot.
CONCLUSIONS CONCLUSIONS
This study will assess intervention feasibility and acceptability in the target populations and determine preliminary efficacy of the intervention to increase employment and reduce vulnerability to HIV when implemented in a community-based setting serving LGBTQ youth of color. Testing the intervention in a community setting is an opportunity to evaluate how recruitment, retention, and other outcomes are impacted by delivery in a venue akin to where this intervention could eventually be used by nonresearchers. If W2P demonstrates feasibility and acceptability, a larger multisite trial implemented in multiple community settings serving YMSM, YTW, and GNC youth of color is planned.
TRIAL REGISTRATION BACKGROUND
ClinicalTrials.gov NCT03313310; https://clinicaltrials.gov/ct2/show/NCT03313310.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID) UNASSIGNED
DERR1-10.2196/18051.

Identifiants

pubmed: 32915162
pii: v9i9e18051
doi: 10.2196/18051
pmc: PMC7519435
doi:

Banques de données

ClinicalTrials.gov
['NCT03313310']

Types de publication

Journal Article

Langues

eng

Pagination

e18051

Informations de copyright

©Brandon J Hill, Darnell N Motley, Kris Rosentel, Alicia VandeVusse, Robert Garofalo, Lisa M Kuhns, Michele D Kipke, Sari Reisner, Betty Rupp, Rachel West Goolsby, Micah McCumber, Laura Renshaw, John A Schneider. Originally published in JMIR Research Protocols (http://www.researchprotocols.org), 11.09.2020.

Références

Ann Behav Med. 2014 Feb;47(1):5-16
pubmed: 24317955
Int J STD AIDS. 2017 May;28(6):602-607
pubmed: 27389778
AIDS Behav. 2014 Jan;18(1):10-25
pubmed: 23620241
Curr HIV/AIDS Rep. 2016 Dec;13(6):359-366
pubmed: 27739018
J Adolesc. 2011 Dec;34(6):1151-65
pubmed: 22118508
J Acquir Immune Defic Syndr. 2010 Apr;53(5):661-4
pubmed: 19927006
Lancet Infect Dis. 2013 Mar;13(3):214-22
pubmed: 23260128
N Engl J Med. 2014 May 1;370(18):1679-81
pubmed: 24785205
Lancet. 2015 Jan 17;385(9964):274-86
pubmed: 25059941
AIDS Behav. 2013 Jul;17(6):2031-44
pubmed: 23553347
J Adolesc Health. 2010 Mar;46(3 Suppl):S75-91
pubmed: 20172462
Glob Public Health. 2011;6 Suppl 3:S293-309
pubmed: 21745027
AIDS Behav. 2017 Dec;21(12):3366-3430
pubmed: 29159594
J Epidemiol Community Health. 2002 Aug;56(8):624-30
pubmed: 12118056
Psychol Bull. 2003 Sep;129(5):674-697
pubmed: 12956539
JMIR Res Protoc. 2020 Aug 10;9(8):e16401
pubmed: 32773376
Implement Sci. 2015 Apr 17;10:50
pubmed: 25889582
Curr HIV/AIDS Rep. 2017 Aug;14(4):141-152
pubmed: 28752285
J Acquir Immune Defic Syndr. 2013 Jun 1;63 Suppl 1:S26-31
pubmed: 23673882
Arch Sex Behav. 2018 Jul;47(5):1517-1527
pubmed: 29305773
Prev Sci. 2015 Nov;16(8):1147-58
pubmed: 26031542
Clin Trials. 2018 Feb;15(1):44-52
pubmed: 28862483
Am J Public Health. 2012 Sep;102(9):1751-7
pubmed: 22873480
Am J Public Health. 1999 Sep;89(9):1406-9
pubmed: 10474560
AIDS Behav. 2017 Jul;21(7):2215
pubmed: 27435072
J Occup Health Psychol. 2002 Oct;7(4):302-312
pubmed: 12396064
J Acquir Immune Defic Syndr. 2017 Jan 1;74(1):21-29
pubmed: 27632233
Am J Public Health. 2015 Feb;105(2):e75-82
pubmed: 25521875
Am J Public Health. 2006 Jun;96(6):1034-7
pubmed: 16131645
AIDS Behav. 2017 Mar;21(3):833-844
pubmed: 27624727
Implement Sci. 2014 Jan 06;9:5
pubmed: 24387142
J Acquir Immune Defic Syndr. 2010 Dec;55 Suppl 2:S132-5
pubmed: 21406983
Transgend Health. 2017;2(1):29-34
pubmed: 28795154
AIDS Behav. 2008 Jan;12(1):1-17
pubmed: 17694429
Implement Sci. 2009 Nov 23;4:76
pubmed: 19930653
J Health Care Poor Underserved. 2010 Aug;21(3):879-97
pubmed: 20693733
J Urban Health. 2005 Mar;82(1 Suppl 1):i35-42
pubmed: 15738322
J Acquir Immune Defic Syndr. 2008 May 1;48(1):97-103
pubmed: 18344875
Sex Transm Infect. 2014 Aug;90(5):430-3
pubmed: 24714446
LGBT Health. 2016 Jun;3(3):219-24
pubmed: 27002852
J Natl Med Assoc. 2004 Jan;96(1):97-107
pubmed: 14746359
Ann Behav Med. 2005 Apr;29 Suppl:66-75
pubmed: 15921491
J Acquir Immune Defic Syndr. 2010 Dec;55 Suppl 2:S91-3
pubmed: 21406995
Am J Prev Med. 2016 Oct;51(4 Suppl 2):S140-7
pubmed: 27402185
AIDS Care. 2011 Apr;23(4):435-43
pubmed: 21271396
JMIR Res Protoc. 2020 Aug 10;9(8):e16384
pubmed: 32773383
Am J Public Health. 2013 Oct;103(10):1820-9
pubmed: 23153142
AIDS Care. 2019 Mar;31(3):364-369
pubmed: 30227719
J Public Health Manag Pract. 2006 Nov;Suppl:S10-6
pubmed: 17035894
J Acquir Immune Defic Syndr. 2010 Dec;55 Suppl 1:S27-31
pubmed: 21045596
Milbank Q. 2012 Jun;90(2):311-46
pubmed: 22709390
AIDS. 2007 Oct 1;21(15):2083-91
pubmed: 17885299
AIDS Educ Prev. 2000;12(5 Suppl):87-98
pubmed: 11063072
BMC Public Health. 2012 Apr 20;12:292
pubmed: 22520027
AIDS Behav. 2009 Jun;13(3):532-44
pubmed: 19267264

Auteurs

Brandon J Hill (BJ)

Planned Parenthood Great Plains, Overland Park, KS, United States.

Darnell N Motley (DN)

Center for Interdisciplinary Inquiry and Innovation in Sexual and Reproductive Health, Department of Obstetrics and Gynecology, University of Chicago, Chicago, IL, United States.

Kris Rosentel (K)

Center for Interdisciplinary Inquiry and Innovation in Sexual and Reproductive Health, Department of Obstetrics and Gynecology, University of Chicago, Chicago, IL, United States.

Alicia VandeVusse (A)

Guttmacher Institute, New York, NY, United States.

Robert Garofalo (R)

Division of Adolescent Medicine, Ann & Robert H Lurie Children's Hospital, Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.

Lisa M Kuhns (LM)

Division of Adolescent Medicine, Ann & Robert H Lurie Children's Hospital, Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.

Michele D Kipke (MD)

Division of Research on Children, Youth, and Families, Children's Hospital Los Angeles, Los Angeles, CA, United States.

Sari Reisner (S)

Fenway Health, The Fenway Institute, Boston, MA, United States.

Betty Rupp (B)

Collaborative Studies Coordinating Center, Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.

Rachel West Goolsby (R)

Collaborative Studies Coordinating Center, Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.

Micah McCumber (M)

Collaborative Studies Coordinating Center, Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.

Laura Renshaw (L)

Collaborative Studies Coordinating Center, Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.

John A Schneider (JA)

Department of Medicine, University of Chicago, Chicago, IL, United States.

Classifications MeSH